A recent study has demonstrated that upregulation of SNHG16 promotes diabetes-associated retinal vascular endothelial cell (RMEC) dysfunction by activating the NF-κB and PI3K/AKT pathways [18], but the exact mechanism remains unclear. The gene discussed is NFKB1; the disease is diabetes mellitus.